Diagnostic value of GeneXpert MTB/RIF in bronchoalveolar lavage fluid for pulmonary non-tuberculosis mycobacterial in acid-fast stain smear-positive and GeneXpert MTB/RIF-negative cases

Diagnostic value of GeneXpert MTB/RIF

2025-06-13

(Press-News.org) Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested real-time fluorescence quantitative nucleic acid amplification detection technology [Xpert Mycobacterium tuberculosis (MTB)/rifampicin (RIF)] in bronchoalveolar lavage fluid (BALF) acid-fast smear-positive cases.

Methods: Between 1 January 2017 and 30 June 2022, 365 patients who underwent fibreoptic bronchoscopy and had positive acid-fast smears of BALF were examined using Xpert MTB/RIF. The mycobacteria growth indicator tube (MGIT) 960 was used for rapid sputum culture and traditional drug sensitivity testing. Combined with mycobacterial culture and drug sensitivity results, Xpert results of alveolar lavage fluid were analysed to guide diagnosis and treatment.

Results: The sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) of Xpert detection for diagnosing NTM lung disease in acid-fast smear-positive cases were 100% (45/45), 99.68% (310/311), 97.83% (45/46) and 100% (310/310), respectively.

Conclusions: Xpert MTB/RIF in alveolar lavage fluid can not only detect RIF resistance but also distinguish pulmonary TB from NTM pulmonary disease in patients with positive acid-fast smears.

Keywords: Bronchoalveolar lavage fluid (BALF); acid-fast smear-positive; Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF); pulmonary tuberculosis (pulmonary TB); non-tuberculous mycobacterial lung disease

Highlight box Key findings

• Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF) in alveolar lavage fluid can not only detect rifampicin resistance but also distinguish pulmonary tuberculosis (TB) from non-tuberculosis mycobacterial (NTM) pulmonary disease in patients with positive acid-fast smears.

What is known and what is new?

• GeneXpert MTB/RIF for rapid diagnosis of TB and rifampicin resistance.

• Xpert MTB/RIF in alveolar lavage fluid can not only detect rifampicin resistance but also distinguish pulmonary TB from NTM pulmonary disease in patients with positive acid-fast smears.

What is the implication, and what should change now?

• The GeneXpert MTB/RIF technology can be extended to the diagnosis of tuberculosis and can be combined with other NTB diagnostic methods.

END

ELSE PRESS RELEASES FROM THIS DATE:

BGI Genomics successfully concludes first Southeast Asia training workshop

2025-06-13

BGI Genomics has successfully wrapped up its inaugural Whole Exome Sequencing (WES) Interpretation of Genetic Diseases Training Workshop for Southeast Asia, marking a significant milestone in international genomics education. Held at the BGI Center in late May, the workshop brought together emerging healthcare professionals and researchers from Thailand, Indonesia, and Vietnam for a week of intensive, hands-on learning. Comprehensive Learning Curriculum The program aimed to improve genetic disease diagnosis in Southeast Asia. It offered both theoretical lessons and hands-on ...

Rare ovarian tumor discovered during postmenopausal vault prolapse evaluation

2025-06-13

“The incidental discovery of a pure SCT in an atrophic ovary during pelvic surgery in a postmenopausal woman is exceedingly rare.” BUFFALO, NY — June 13, 2025 — A new case report was published in Volume 12 of Oncoscience on May 22, 2025, titled “A rare case: Pure Sertoli cell tumor uncovered in atrophic ovary during postmenopausal vault prolapse evaluation.” In this case report, corresponding author Naina Kumar from the All India Institute of Medical Sciences and team describe a ...

Innovative algorithm revolutionizes chip placement for advanced circuit design

2025-06-13

In the fast-paced realm of semiconductor technology, optimizing chip design to meet the dual challenges of performance enhancement and cost reduction has emerged as a pivotal focus. A new study published in Engineering introduces a groundbreaking approach to address this challenge, presenting an exact algorithm for placement optimization in mixed-cell-height (MCH) circuits. Led by researchers Binqi Zhang, Lu Zhen, and Gilbert Laporte, the work tackles the intricate task of arranging diverse circuit cells within constrained chip regions while adhering to critical design rules, including ...

Hereditary mutations in BRCA genes increase risk of rare lymphoma among women with breast cancer who received textured breast implants

2025-06-13

(WASHINGTON, June 13, 2025) – Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after mastectomy were 16 times more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare T-cell lymphoma, compared with similar women without these genetic mutations, according to a study published today in Blood Advances. “Our findings show that BRCA1 and BRCA2 mutations are a significant risk factor for developing this type of lymphoma, confirming earlier suggestions of a possible role. It’s possible ...

Improving resilience to tsunamis and earthquakes via predictions of waste disposal times

2025-06-13

Tsunamis and earthquakes pose devastating threats to coastal communities worldwide. However, beyond the immediate destructive power of these events, the negative impact of the disaster waste they produce is sometimes overlooked. For example, when the 2011 Great East Japan Earthquake struck, approximately 23 million tons of waste were generated, severely hindering post-disaster recovery processes. Similarly, the 2024 Noto Peninsula Earthquake produced 2.7 million tons of waste—equivalent to seven years of normal waste disposal. Thus, rapid processing of disaster waste is essential for restoring community functionality, making it a critical ...

Scientists extend facial expression analysis system to include bonobos

2025-06-13

Researchers have successfully adapted a standardized system for analyzing facial expressions to include bonobos, our closest living relatives alongside chimpanzees. The study, led by an international team of scientists from multiple institutions including Leipzig University and the Max Planck Institute for Evolutionary Anthropology, extends the Chimpanzee Facial Action Coding System (ChimpFACS) to another species closely related to humans and chimpanzees, bonobos. The research confirms that bonobos possess a repertoire of 28 distinct facial movements, including ...

SGLT2 inhibitor empagliflozin treatment stabilizes kidney function in patients who have had a heart attack

2025-06-13

Journal: Nature Cardiovascular Research – June 13 Online Issue Author: Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Title: Secondary analysis of the EMPACT-MI Trial Reveals Cardiovascular-Kidney Efficacy and Safety of Empagliflozin After Acute Myocardial Infarction Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have been questions as to whether it is safe to use these drugs ...

City of Hope developed a foundational map of tumor cells for personalized brain cancer treatments

2025-06-13

LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment. The leading-edge brain cancer research provides foundational knowledge that one day will improve the practice of precision medicine and allow oncologists to deliver more personalized therapies to cancer patients. Tiny DNA molecules ...

Pangolins in Africa hunted for food rather than illicit scales trade – with meat ranked as ‘tastiest’

2025-06-13

Study suggests that appetite for bushmeat – rather than black market for scales to use in traditional Chinese medicine – may be driving West Africa’s illegal hunting of one of the world’s most threatened mammals. Interviews with hundreds of hunters show pangolins overwhelmingly caught for food, with majority of scales thrown away. Survey work shows pangolin is considered the most palatable meat in the region. The vast majority of pangolin hunting in African ...

How solvents shape precision drug delivery

2025-06-13

Even the best products won’t meet expectations if they are packed poorly — packaging matters. The same goes for drug delivery. Osaka Metropolitan University researchers have uncovered the critical role played by solvents in how effectively drugs can be loaded into metal–organic frameworks (MOFs), a promising class of drug carriers. Their findings shed light on a previously overlooked part of the loading process, with the potential to boost the efficiency of how medications are delivered inside the body. To treat diseases effectively, it’s not just the medicine that counts — but also how that medicine is delivered into our ...

LAST 30 PRESS RELEASES:

Parents of children with health conditions less confident about a positive school year

New guideline standardizes consent for research participants in Canada

Research as reconciliation: Oil sands and health

AI risks overwriting history and the skills of historians have never been more important, leading academic outlines in new paper

The Lancet Diabetes & Endocrinology: Higher doses of semaglutide can safely enhance weight loss and improve health for adults living with obesity, two new clinical trials confirm